ROK
51
12
WM
77
-5
JPM
63
-10
PSX
42
-5
TRIP
55
3
PEG
53
-4
DFS
59
-3
CCI
41
-8
ORCL
59
-10
PRU
53
-7
ED
40
-3
MTCH
40
-6
EQT
59
2
TXN
55
2
HP
34
2
DE
26
-2
CF
45
3
CTAS
64
3
URI
68
3
VRSN
52
2
ROK
51
12
WM
77
-5
JPM
63
-10
PSX
42
-5
TRIP
55
3
PEG
53
-4
DFS
59
-3
CCI
41
-8
ORCL
59
-10
PRU
53
-7
ED
40
-3
MTCH
40
-6
EQT
59
2
TXN
55
2
HP
34
2
DE
26
-2
CF
45
3
CTAS
64
3
URI
68
3
VRSN
52
2
Financhill
Back

Puma Biotechnology Quote, Financials, Valuation and Earnings

Sell
37

PBYI
Puma Biotechnology

Last Price:
4.44
Seasonality Move:
45.48%

7 Day Trial

ALL ACCESS PASS

$ 7

Puma Biotechnology Price Quote

$4.44
+0.07 (+1.6%)
(Updated: May 21, 2024 at 9:45 AM ET)

Puma Biotechnology Key Stats

Sell
37
Puma Biotechnology (PBYI) is a Sell
Day range:
$4.10 - $4.83
52-week range:
$2.13 - $7.73
Dividend yield:
0%
P/E ratio:
9.71
P/S ratio:
0.92
P/B ratio:
4.13%
Volume:
1.6M
Avg. volume:
391.2K
1-year change:
51.21%
Market cap:
$210.8M
Revenue:
$235.6M
EPS:
$0.32

How Much Does Puma Biotechnology Make?

Is Puma Biotechnology Growing As A Company?

  • What Is Puma Biotechnology's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.17%
  • What Is Puma Biotechnology's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Puma Biotechnology Stock Price Performance

What Is Puma Biotechnology 52-Week High & Low?

Puma Biotechnology Price To Free Cash Flow

Is It Risky To Buy Puma Biotechnology?

  • How Much Debt Does Puma Biotechnology Have?
    Total long term debt quarterly is $100M
  • How Much Cash Does Puma Biotechnology Have?
    Cash and short term investments quarterly total is $107.2M
  • What Is Puma Biotechnology’s Book Value Per Share?
    Book value per share is 1.06

Is Puma Biotechnology Cash Flow Positive?

  • What Is PBYI Cash Flow From Operations?
    Cash flow from operations (TTM) is $35.6M
  • What Is Puma Biotechnology’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $0
  • What Is Puma Biotechnology’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$20.8M

Puma Biotechnology Return On Invested Capital

  • Is Management Doing A Good Job?
    PBYI return on invested capital is 11.05%
  • What Is Puma Biotechnology Return On Assets?
    ROA measures how assets are converting to revenues and is 7.36%
  • What Is PBYI Return On Equity?
    ROE is a measure of profitability and is 38.55%

Puma Biotechnology Earnings Date & Stock Price

Puma Biotechnology Competitors

  • Who Are Puma Biotechnology's Competitors?
    Below is a list of companies who compete with Puma Biotechnology or are related in some way:
    • ADMA Biologics Inc (ADMA)
    • Pfizer Inc (PFE)
    • Sarepta Therapeutics Inc (SRPT)
    • United Therapeutics Corp (UTHR)
    • Vanda Pharmaceuticals Inc (VNDA)

Puma Biotechnology Dividend Yield

Data Unavailable

Puma Biotechnology Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 67.74%
Revenue: -17.07% -10.77%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 4.33
Downside from Last Price: -0.84%

Major Shareholders

  • How many PBYI shares are owned by institutional investors?
    32.8M PBYI shares are owned by institutional investors
  • How many PBYI shares are owned by insiders?
    8.4M PBYI shares are owned by insiders